Orexigen Therapeutics

Developing and marketing drugs for the treatment of obesity.

placeSan Diego, California, United States calendar_todayFounded 2002 groups132 employees language orexigen.com

Registered entities

Investor mix

16 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital956%
Private equity425%
Other / undisclosed319%
Coming soon